Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "Collagen and associated proteoglycan core proteins in extracellular matrix" target refers to the primary structural scaffold of the interstitial space and basement membranes, often termed the "ECM core" [1]. This complex is composed of various collagen types (predominantly I, III, and IV) and small leucine-rich proteoglycans (SLRPs) such as decorin and biglycan, which together dictate tissue mechanics and regulate cell behavior [2]. In healthy physiology, these proteins provide tensile strength and serve as a reservoir for signaling molecules; however, their pathological accumulation is the defining feature of fibrosis in organs like the liver, lungs, and kidneys [3]. In the tumor microenvironment, a dense collagenous stroma (desmoplasia) acts as a physical barrier to drug delivery and a biochemical promoter of epithelial-mesenchymal transition (EMT) and metastasis [4]. Therapeutic interventions targeting this matrix include direct enzymatic degradation using collagenases for localized fibrotic conditions, and systemic inhibitors of collagen synthesis or cross-linking (e.g., LOX/LOXL2 inhibitors) for broader fibrotic diseases [5]. Monitoring these components via serum biomarkers like PRO-C3 or C-telopeptides is increasingly used in clinical trials to assess the efficacy of anti-fibrotic and anti-stromal therapies [6]. Sources: [1] Frantz, C., et al. (2010). "The extracellular matrix at a glance." Journal of Cell Science. [2] Iozzo, R. V., & Schaefer, L. (2015). "Proteoglycan form and function." Matrix Biology. [3] Henderson, N. C., et al. (2020). "Fibrosis: from mechanisms to medicines." Nature. [4] Winkler, J., et al. (2020). "Concepts of extracellular matrix remodelling in cancer." Nature Communications. [5] Martinez-Salgado, C., et al. (2021). "Targeting the Extracellular Matrix in Fibrosis." International Journal of Molecular Sciences. [6] Karsdal, M. A., et al. (2017). "The biochemistry of the extracellular matrix." Academic Press.
Direct enzymatic degradation of collagen fibrils, inhibition of TGF-beta-mediated collagen synthesis, and inhibition of lysyl oxidase-mediated cross-linking.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Collagen and associated proteoglycan core proteins in extracellular matrix.